Sponsored

http://www.jiuyuangene.net/

鈥?Development History
On December 31, 1993, Hangzhou Jiuyuan Gene Engineering Co., Ltd. was registered and established in Hangzhou New High-tech Development Zone.
On October 14, 1996,the company obtained the Trial-
Generic Name: Enoxaparin Sodium Injection
鈼?The only LWMH is recommended by ACC, ESC and CSC to cure UA and NSTEMI.
鈼?The only LWMH is approved to cure STEMI.
鈼?The only enoxaparin sodium which complies with EP 8.0 standard, and has EU and USA process patent in China.
鈼?Consistent with structure characteristics t of original drug Lovenox/Clexane, compare with other generic drugs, YINUOJIA has highest biologically equivalent and specific value of anti-FXa/anti-FIIa activity. At low risk of bleeding and high safety.
鈼?Obtained the special project support of new medicine development form the state council, and excellence award of state patent for invention, Class B drugs of National medical insurance, Basic drugs in some provinces and cities.
Dosage Form: Injection
Specification: 0.4ml锛?000AxaIU锛?.6ml锛?000AxaIU
[Indication]
1. Prevention of venous thromboembolic diseases, especially thrombosis associated with orthopedic or general surgery.
2. Treatment of established deep venous thromboembolic with or without pulmonary embolism.
3. Prevention of thrombus formation in the extra-corporal circulation during hemodialysis.
4. Treatment of acute unstable angina and non-Q-wave myocardial infraction, administered concurrently with aspirin.
5. Treatment of acute ST-segment elevation myocardial infarction with thrombolytics or combined with percutaneous coronary intervention (PCI).
GUYOUDAO
[Name]
Chemical Name: Recombinant Human Bone Morphogenetic Protein-2
A new type bone repairing material which has biological activity.
Specification: 0.3mg rhBMP-2/vial, 0.4mg rhBMP-2/vial, 0.4mg-鈪?rhBMP-2/vial, 0.5mg-鈪爎hBMP-2/vial, 0.5mg-鈪hBMP-2/vial, 0.6mg rhBMP-2/vial, 0.6mg-鈪爎hBMP-2/vial, 0.75mg rhBMP-2/vial, 0.8mg rhBMP-2/vial, 0.8 mg-鈪爎hBMP-2/vial, 1.0mg rhBMP-2/vial, 1.0mg-鈪爎hBMP-2/vial, 1.2mg rhBMP-2/vial, 1.5mg rhBMP-2/vial, 1.6mg rhBMP-2/vial, 2.0mg rhBMP-2/vial, 2.4mg rhBMP-2/vial, 3.0 mg rhBMP-2/vial
[Indication]
Indicated in filling and repairing for various reasons caused bone defect, bone non-union, delayed bone healing or unhealing, as well as treated in spinal fusion, joint fusion and orthopedic bone graft repair.
Communist Party, the company makes all efforts to promote the construction of corporate culture and build a learning and focused efficient team.semaglutidefreezed-driedpowerSuppliers
website:http://www.jiuyuangene.net/
http://www.jiuyuangene.net/ 鈥?Development History On December 31, 1993, Hangzhou Jiuyuan Gene Engineering Co., Ltd. was registered and established in Hangzhou New High-tech Development Zone. On October 14, 1996,the company obtained the Trial- Generic Name: Enoxaparin Sodium Injection 鈼?The only LWMH is recommended by ACC, ESC and CSC to cure UA and NSTEMI. 鈼?The only LWMH is approved to cure STEMI. 鈼?The only enoxaparin sodium which complies with EP 8.0 standard, and has EU and USA process patent in China. 鈼?Consistent with structure characteristics t of original drug Lovenox/Clexane, compare with other generic drugs, YINUOJIA has highest biologically equivalent and specific value of anti-FXa/anti-FIIa activity. At low risk of bleeding and high safety. 鈼?Obtained the special project support of new medicine development form the state council, and excellence award of state patent for invention, Class B drugs of National medical insurance, Basic drugs in some provinces and cities. Dosage Form: Injection Specification: 0.4ml锛?000AxaIU锛?.6ml锛?000AxaIU [Indication] 1. Prevention of venous thromboembolic diseases, especially thrombosis associated with orthopedic or general surgery. 2. Treatment of established deep venous thromboembolic with or without pulmonary embolism. 3. Prevention of thrombus formation in the extra-corporal circulation during hemodialysis. 4. Treatment of acute unstable angina and non-Q-wave myocardial infraction, administered concurrently with aspirin. 5. Treatment of acute ST-segment elevation myocardial infarction with thrombolytics or combined with percutaneous coronary intervention (PCI). GUYOUDAO [Name] Chemical Name: Recombinant Human Bone Morphogenetic Protein-2 A new type bone repairing material which has biological activity. Specification: 0.3mg rhBMP-2/vial, 0.4mg rhBMP-2/vial, 0.4mg-鈪?rhBMP-2/vial, 0.5mg-鈪爎hBMP-2/vial, 0.5mg-鈪hBMP-2/vial, 0.6mg rhBMP-2/vial, 0.6mg-鈪爎hBMP-2/vial, 0.75mg rhBMP-2/vial, 0.8mg rhBMP-2/vial, 0.8 mg-鈪爎hBMP-2/vial, 1.0mg rhBMP-2/vial, 1.0mg-鈪爎hBMP-2/vial, 1.2mg rhBMP-2/vial, 1.5mg rhBMP-2/vial, 1.6mg rhBMP-2/vial, 2.0mg rhBMP-2/vial, 2.4mg rhBMP-2/vial, 3.0 mg rhBMP-2/vial [Indication] Indicated in filling and repairing for various reasons caused bone defect, bone non-union, delayed bone healing or unhealing, as well as treated in spinal fusion, joint fusion and orthopedic bone graft repair. Communist Party, the company makes all efforts to promote the construction of corporate culture and build a learning and focused efficient team.semaglutidefreezed-driedpowerSuppliers website:http://www.jiuyuangene.net/
WWW.JIUYUANGENE.NET
China Finished Dosage Form, API, Oncology Injection Suppliers, Manufacturers, Factory - JIUYUAN
Hangzhou Jiuyuan Gene Engineering Co., Ltd. is a top-biotech joint venture specializing in the research, development, manufacture and marketing of pharmaceuticals based on gene engineering and biochemical technology since 1993.
0 Comments 0 Shares
Sponsored

Sponsored


Don't forget, ads time: PentaVerge | AQU | Debwan | ICICTE | Nasseej | ESol | OUST | CorpSNet | PoemsBook | TopDeals | TheReaderView